APA (7th ed.) Citation

Bechter, O., Loquai, C., Champiat, S., Baurain, J., Grob, J., Utikal, J., . . . Lebbe, C. (2025). A phase I, first-in-human, dose-escalation, expansion trial of cytokine-encoding synthetic mRNA mixture alone or with cemiplimab in advanced solid tumors: Clinical trials : immunotherapy. Clinical cancer research, 31(12), . https://doi.org/10.1158/1078-0432.CCR-24-1983

Chicago Style (17th ed.) Citation

Bechter, Oliver, et al. "A Phase I, First-in-human, Dose-escalation, Expansion Trial of Cytokine-encoding Synthetic MRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors: Clinical Trials : Immunotherapy." Clinical Cancer Research 31, no. 12 (2025). https://doi.org/10.1158/1078-0432.CCR-24-1983.

MLA (9th ed.) Citation

Bechter, Oliver, et al. "A Phase I, First-in-human, Dose-escalation, Expansion Trial of Cytokine-encoding Synthetic MRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors: Clinical Trials : Immunotherapy." Clinical Cancer Research, vol. 31, no. 12, 2025, https://doi.org/10.1158/1078-0432.CCR-24-1983.